COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that it will report its financial results for the quarter ended September 30, 2007, on Monday, November 12, 2007. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Cary J. Claiborne, Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Monday, November 12, 2007 at 9:00 a.m. EST. To access the web cast, visit the Investor Relations section of the company’s website at http://investor.osiris.com/events.cfm. Alternatively, callers may participate in the conference call by dialing (877) 440-5807 (U.S. participants) or (719) 325-4889 (international participants).
